Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
What Growth Projections are in Place for the Antibody Contract Manufacturing Market Between 2024-2033?
In recent times, the antibody contract manufacturing market has seen a swift expansion in its size. A surge from $12.84 billion in 2023 to $14.71 billion in 2024 is projected, indicating a compound annual growth rate (CAGR) of 14.6%. The previous period’s growth can be credited to factors such as heightened demand for monoclonal antibodies, a shift in preference towards personalized medicine, maximization of cost efficiency, rigid regulatory protocols, and the international spread of biologics.
In the upcoming years, the antibody contract manufacturing market is predicted to undergo swift expansion, increasing to a whopping $25.27 billion in 2028 with a Compound Annual Growth Rate (CAGR) of 14.5%. Factors contributing to this growth during the prediction period include the escalation in R&D investments, the proliferation of bispecific and multispecific antibodies, the advent of antibody-drug conjugates (ADCs), the improvement in healthcare infrastructure, and the expansion of government initiatives. Key trends set to be observed in the forecast period include pioneering downstream processing techniques, digitalization and data analytics, cutting-edge upstream technologies, sustainability initiatives, and the integration of contract development and manufacturing (CDMO).
Claim Your Free Sample of the Global Antibody Contract Manufacturing Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12665&type=smp
What Are the Major Factors Contributing to the antibody contract manufacturing Market Expansion?
The surge in clinical trials is anticipated to fuel forward momentum in the antibody contract manufacturing market. Clinical trials are research endeavors carried out on human participants to determine the safety and efficacy of novel medical treatments, interventions, or diagnostic approaches. As the volume of clinical trials involving antibody-related therapies or diagnostics grows, the need for premium antibodies likewise increases, ensuring a punctual and regulation-compliant supply for these trials. For example, information from ClinicalTrials.gov, an entity of the National Institutes of Health (NIH), a US government agency tasked with conducting and supporting medical research, showed that across all of America’s 50 states and 221 countries, there was a rise in clinical trials registrations from 399,499 in 2022 to 437,533 in 2023. Moreover, 241,498 studies, roughly 53% of the total registered, were recorded outside of the United States, whereas only 140,492 studies, or 31% were recorded in the United States. Hence, this growing number of clinical trials is propelling the expansion of the antibody contract manufacturing market.
Which Key Segments Shape the Antibody Contract Manufacturing Market?
1) By Product: Monoclonal Antibodies, Polyclonal Antibodies, Other Products
2) By Source: Mammalian, Microbial
3) Scale Of Operation: Preclinical, Clinical, Commercial
4) By End-User: Biopharmaceutical Companies, Research Laboratories, Other End Users
What Are the Transformative Trends Influencing the Antibody Contract Manufacturing Market?
The rise of technological advancements is a significant trend being observed in the antibody contract manufacturing market. Major players within this market are embracing innovative technologies in order to remain competitive. An example of this occurred in October 2021 when Merck KGaA, a science and technology firm based in Germany, launched an innovative solution – ChetoSensar – designed to tackle solubility issues in antibody-drug conjugates (ADCs). Merck KGaA plans to utilize their proficiency in contract development manufacturing to aid the creation of next-generation antibody-drug conjugates and enhance the potency of high-potency active pharmaceutical ingredients (HPAPIs). They aim to achieve this by improving these compounds’ solubility using the groundbreaking ChetoSensar technology.
Order Now for Fast Delivery of Your Antibody Contract Manufacturing Market Report!
What Regions Are Leading the Growth Trajectory of the Antibody Contract Manufacturing Market?
North America was the largest region in the antibody contract manufacturing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibody contract manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The Antibody Contract Manufacturing Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the antibody contract manufacturing market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Antibody Contract Manufacturing Market Include
1. Antibody Contract Manufacturing Market Executive Summary
2. Antibody Contract Manufacturing Market Segments
3. Antibody Contract Manufacturing Market Size And Template Market Growth Rate
4. Key Antibody Contract Manufacturing Market Trends
5. Major Antibody Contract Manufacturing Market Drivers
……
25. Key Mergers And Acquisitions In The Antibody Contract Manufacturing Market
26. Top Antibody Contract Manufacturing Companies
27. Antibody Contract Manufacturing Market Opportunities And Strategies
28. Antibody Contract Manufacturing Market, Conclusions And Recommendations
29. Appendix
Discover Related Reports by The Business Research Company:
Pharmaceutical Contract Development And Manufacturing Organization (CMO) Global Market Report 2024
Electronic Contract Manufacturing and Design Services Global Market Report 2024
Contract Development Manufacturing Organizations Global Market Report 2024
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
